RAPID MICRO BIOSYSTEMS, INC. (RPID) — SEC Financial Statements & Analysis

RAPID MICRO BIOSYSTEMS, INC. (RPID) is a laboratory analytical instruments company, incorporated in DE. RAPID MICRO BIOSYSTEMS, INC. trades on Nasdaq as: RPID. RAPID MICRO BIOSYSTEMS, INC. (RPID)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07. Based on that filing, RAPID MICRO BIOSYSTEMS, INC. carries a market cap of $83.64M, a P/E ratio of -1.63x, a P/B ratio of 4.71x, a P/S ratio of 2.38x, an enterprise value of $87.81M, and an EV/EBITDA multiple of -1.88x. On profitability, it posts a gross margin of 24.20%, an operating margin of -141.45%, a net margin of -145.55%, a Return on Equity (ROE) of -141.65%, a Return on Assets (ROA) of -76.40%, and a Return on Invested Capital (ROIC) of -168.23%. Per share, it reports EPS of $-1.06, diluted EPS of $-1.06, free cash flow per share of $-0.84, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 16.13% year-over-year, net income growth of 16.07% year-over-year, and EPS growth of 7.19% year-over-year. On the balance sheet, it maintains a current ratio of 2.55x, a quick ratio of 1.39x, working capital of $28.11M, a debt-to-equity ratio of 2.29x, a debt ratio of 0.7, an interest coverage ratio of -21.16x, free cash flow of $-40.84M (TTM), and net debt of $4.17M. Figures sourced from SEC EDGAR.

Market Cap

$83.64M

P/E TTM

-1.63x

EPS TTM

$-1.06

P/B TTM

4.71x

ROE TTM

-141.65%

ROA TTM

-76.40%

Debt To Equity

2.29x

Free Cash Flow TTM

$-40.84M

Net Revenue TTM Growth 1Y

16.13%

Data as of 2026-06-30 · Source: SEC EDGAR